1. Home
  2. MOMO vs NTLA Comparison

MOMO vs NTLA Comparison

Compare MOMO & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOMO
  • NTLA
  • Stock Information
  • Founded
  • MOMO 2011
  • NTLA 2014
  • Country
  • MOMO China
  • NTLA United States
  • Employees
  • MOMO N/A
  • NTLA N/A
  • Industry
  • MOMO Computer Software: Prepackaged Software
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • MOMO Technology
  • NTLA Health Care
  • Exchange
  • MOMO Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • MOMO 909.4M
  • NTLA 794.5M
  • IPO Year
  • MOMO 2014
  • NTLA 2016
  • Fundamental
  • Price
  • MOMO $8.28
  • NTLA $9.20
  • Analyst Decision
  • MOMO Buy
  • NTLA Buy
  • Analyst Count
  • MOMO 2
  • NTLA 20
  • Target Price
  • MOMO $10.00
  • NTLA $36.60
  • AVG Volume (30 Days)
  • MOMO 1.6M
  • NTLA 6.0M
  • Earning Date
  • MOMO 06-05-2025
  • NTLA 08-07-2025
  • Dividend Yield
  • MOMO 3.37%
  • NTLA N/A
  • EPS Growth
  • MOMO N/A
  • NTLA N/A
  • EPS
  • MOMO 1.06
  • NTLA N/A
  • Revenue
  • MOMO $1,450,201,337.00
  • NTLA $45,569,000.00
  • Revenue This Year
  • MOMO $0.97
  • NTLA N/A
  • Revenue Next Year
  • MOMO $4.25
  • NTLA N/A
  • P/E Ratio
  • MOMO $8.11
  • NTLA N/A
  • Revenue Growth
  • MOMO N/A
  • NTLA N/A
  • 52 Week Low
  • MOMO $5.12
  • NTLA $5.90
  • 52 Week High
  • MOMO $8.66
  • NTLA $28.18
  • Technical
  • Relative Strength Index (RSI)
  • MOMO 73.10
  • NTLA 57.28
  • Support Level
  • MOMO $8.16
  • NTLA $8.00
  • Resistance Level
  • MOMO $8.66
  • NTLA $10.52
  • Average True Range (ATR)
  • MOMO 0.30
  • NTLA 0.67
  • MACD
  • MOMO 0.11
  • NTLA 0.15
  • Stochastic Oscillator
  • MOMO 85.38
  • NTLA 63.35

About MOMO Hello Group Inc.

Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: